Soleno Therapeutics (SLNO) Change in Account Payables: 2013-2024
Historic Change in Account Payables for Soleno Therapeutics (SLNO) over the last 12 years, with Dec 2024 value amounting to $5.7 million.
- Soleno Therapeutics' Change in Account Payables rose 171.63% to $260,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $1.1 million, marking a year-over-year increase of 326.10%. This contributed to the annual value of $5.7 million for FY2024, which is 313.41% up from last year.
- Soleno Therapeutics' Change in Account Payables amounted to $5.7 million in FY2024, which was up 313.41% from $1.4 million recorded in FY2023.
- Soleno Therapeutics' Change in Account Payables' 5-year high stood at $5.7 million during FY2024, with a 5-year trough of -$1.5 million in FY2022.
- In the last 3 years, Soleno Therapeutics' Change in Account Payables had a median value of $1.4 million in 2023 and averaged $1.9 million.
- As far as peak fluctuations go, Soleno Therapeutics' Change in Account Payables tumbled by 528.51% in 2022, and later skyrocketed by 313.41% in 2024.
- Yearly analysis of 5 years shows Soleno Therapeutics' Change in Account Payables stood at $1.5 million in 2020, then plummeted by 115.73% to -$235,000 in 2021, then slumped by 528.51% to -$1.5 million in 2022, then spiked by 192.89% to $1.4 million in 2023, then surged by 313.41% to $5.7 million in 2024.